This Management's Discussion and Analysis ("MD&A") is intended to provide an
understanding of our financial condition, results of operations and cash flows
by focusing on changes in certain key measures from year to year. This
discussion should be read in conjunction with the Condensed Consolidated
Unaudited Financial Statements contained in this Quarterly Report on Form 10-Q
and the Consolidated Financial Statements and related notes and MD&A appearing
in our Annual Report on Form 10-K as of and for the year ended December 31,
2021. The results of operations for an interim period may not give a true
indication of results for future interim periods or for the year.

Cautionary Statement Regarding Forward Looking Statements


This Quarterly Report on Form 10-Q, including the financial statements and
related notes, contains forward-looking statements that discuss, among other
things, future expectations and projections regarding future developments,
operations and financial conditions. All forward-looking statements are based on
management's existing beliefs about present and future events outside of
management's control and on assumptions that may prove to be incorrect. If any
underlying assumptions prove incorrect, our actual results may vary materially
from those anticipated, estimated, projected or intended. We undertake no
obligation to publicly update or revise any forward-looking statements to
reflect actual results, changes in expectations or events or circumstances after
the date of this Quarterly Report on Form 10-Q.

When this report uses the words "we," "us," or "our," and the "Company," they refer to TREES Corporation (formerly, "General Cannabis Corp").

Our Products, Services, and Customers

Through our two reporting segments, Retail and Cultivation, we provide products to the regulated cannabis industry and its customers, which include the following:


Through our acquisition of TDM, LLC ("TREES Englewood") in September 2021, our
acquisition of Trees Portland, LLC, Trees Waterfront, LLC in December 2021, and
our acquisition of Trees MLK, LLC in January 2022, we operate a retail
dispensary store in Englewood, Colorado and three retail stores in Portland,
Oregon.

Cultivation ("Cultivation Segment")

Through our acquisition of SevenFive Farm in May 2020, we operate a 17,000 square foot licensed light deprivation greenhouse cultivation facility.



                                       23

Table of Contents



During the three months ended September 30, 2022 and 2021, 79% and 24% of
SevenFive's revenue was with one and two customers, respectively. During the
nine months ended September 30, 2022 and 2021, 66% and 12% was with one
customer, respectively. The customer in 2022 is a related party dispensary and
the revenues associated with this customer is eliminated in consolidation.

Discontinued Operations - Operations Consulting and Products



Through Next Big Crop, we delivered comprehensive consulting services to the
cannabis industry that included obtaining licenses, compliance, cultivation,
retail operations, logistical support, facility design and construction, and
expansion of existing operations.

NBC oversaw our wholesale equipment and supply business, operating under the
name "GC Supply," which provided turnkey sourcing and stocking services to
cultivation, retail, and infused products manufacturing facilities. Our products
included building materials, equipment, consumables, and compliance packaging.
NBC also provided operational support for our internal cultivation. On July 16,
2021, we entered into an Asset Purchase Agreement with an individual to sell
substantially all the assets of NBC for a total of $150,000 and 10% of profits
generated by the buyer in the states of Michigan, Mississippi, and Massachusetts
for a period of twelve months from the closing. On August 2, 2021, the sale

of
NBC was completed.

Results of Operations

The following tables set forth, for the periods indicated, statements of operations data. The tables and the discussion below should be read in conjunction with the accompanying condensed consolidated financial statements and the notes thereto in this report.



                                      Three months ended September 30,                           Percent
                                        2022                       2021            Change        Change
Revenues                         $         3,177,177           $   1,665,642    $   1,511,535         91 %
Costs and expenses                       (3,834,374)             (2,537,670)      (1,296,704)         51 %
Other expense                            (1,793,482)               (414,962)      (1,378,520)        332 %
Net loss from continuing
operations before income
taxes                                    (2,450,679)             (1,286,990)      (1,163,689)         90 %
Loss from discontinued
operations                                       195                (40,605)           40,800      (100) %
Loss from operations before
income taxes                     $       (2,450,484)           $ (1,327,595)    $ (1,122,889)         85 %


                                    Nine months ended September 30,                        Percent
                                         2022                2021            Change        Change
Revenues                          $        9,986,212     $   3,028,055    $   6,958,157        230 %
Costs and expenses                      (10,922,952)       (5,653,952)      (5,269,000)         93 %
Other expense                            (2,563,226)       (2,059,885)        (503,341)         24 %
Net loss from continuing

operations before income taxes           (3,499,966)       (4,685,782)     

  1,185,816       (25) %
Loss from discontinued
operations                                     5,478         (377,134)          382,612      (101) %
Loss from operations before
income taxes                      $      (3,494,488)     $ (5,062,916)    $   1,568,428       (31) %


Revenues

The addition of our Retail segment contributed to the significant increase in
revenues for the three and nine months ended September 30, 2022. See Segment
discussions below for further details.

                                       24

  Table of Contents

Costs and expenses

                                          Three months ended September 30,                       Percent
                                             2022                  2021             Change       Change
Cost of sales                          $       2,036,532     $       1,473,209    $   563,323         38 %
Selling, general and administrative            1,462,902               672,981        789,921        117 %
Stock-based compensation                          38,460               131,836       (93,376)       (71) %
Professional fees                                197,565               144,289         53,276         37 %
Depreciation and amortization                     98,915               115,355       (16,440)       (14) %
                                       $       3,834,374     $       2,537,670    $ 1,296,704         51 %


                                          Nine months ended September 30,                       Percent
                                             2022                  2021            Change       Change
Cost of sales                          $       5,856,995     $      2,539,840    $ 3,317,155        131 %
Selling, general and administrative            4,001,816            1,853,731      2,148,085        116 %
Stock-based compensation                         156,961              194,120       (37,159)       (19) %
Professional fees                                716,410              760,437       (44,027)        (6) %
Depreciation and amortization                    190,770              305,824      (115,054)       (38) %
                                       $      10,922,952     $      5,653,952    $ 5,269,000         93 %


Cost of sales increased for the three and nine months ended September 30, 2022
due to the addition of the Retail Segment in the third and fourth quarters of
2021. See Segment discussions below for further details.

Selling, general and administrative expense increased for the three and nine
months ended September 30, 2022, as compared to September 30, 2021, due to the
acquisition of three dispensaries in the third and fourth quarter of 2021 and
one additional dispensary in the first quarter of 2022. This resulted in an
increase in employees and an increase in rent expense.

Professional fees consist primarily of accounting and legal expenses.
Professional fees increased slightly for the three months ended September 30,
2022 as compared to September 30, 2021 due to the increased acquisition activity
in the third quarter of 2022. Professional fees decreased slightly for the nine
months ended September 30, 2022, as compared to the nine months ended September
30, 2021, due to a concentrated effort on reduction of expenses.

Stock-based compensation included the following:



                     Three months ended September 30,                      Percent
                        2022                  2021             Change      Change
Employee awards    $        38,460      $         131,836    $ (93,376)       (71) %
                   $        38,460      $         131,836    $ (93,376)       (71) %


                      Nine months ended September 30,                      Percent
                         2022                  2021            Change      Change
Employee awards    $        156,961      $        194,120    $ (37,159)       (19) %
                   $        156,961      $        194,120    $ (37,159)       (19) %


Employee awards are issued under our 2020 Omnibus Incentive Plan, which was
approved by shareholders on November 23, 2020, and our 2014 Equity Incentive
Plan, which was approved by shareholders on June 26, 2015. Expense varies
primarily due to the number of stock options granted and the share price on the
date of grant. The decrease in expense for the three and nine months ended
September 30, 2022, as compared to September 30, 2021, is due to not issuing
options in the third quarter of 2022.

                                       25

  Table of Contents

Other Expense

                                          Three months ended September 30,                       Percent
                                             2022                  2021             Change       Change
Amortization of debt discount          $       1,285,392     $         216,516    $ 1,068,876        494 %
Interest expense                                 213,833               150,503         63,330         42 %
Loss on extinguishment of debt                   310,622               233,374         77,248         33 %
(Gain) loss on derivative liability             (16,365)              (52,452)         36,087       (69) %
Gain on sale of assets                                 -             (132,979)        132,979      (100) %
                                       $       1,793,482     $         414,962    $ 1,378,520        332 %


                                          Nine months ended September 30,                          Percent
                                             2022                  2021              Change        Change
Amortization of debt discount          $       1,716,334     $         470,306    $   1,246,028        265 %
Interest expense                                 564,229               444,186          120,043         27 %
Loss on extinguishment of debt                   310,622               233,374           77,248         33 %
Loss (gain) on derivative liability             (14,959)             1,043,531      (1,058,490)      (101) %
Gain on sale of assets                          (13,000)             (131,512)          118,512       (90) %
                                       $       2,563,226     $       2,059,885    $     503,341         24 %


Amortization of debt discount and loss on extinguishment of debt increased
during the three and nine months ended September 30, 2022, as compared to
September 30, 2021, due to the senior convertible promissory notes with warrants
("12% Notes") issued in September 2022 and the rollover and repayment of the 10%
Notes. Interest expense increased during the three and nine months ended
September 30, 2022, as compared to September 30, 2021, due to the addition of
the 10% Notes with an interest rate of 10% in 2021. The gain on warrant
derivative liability reflects the change in the fair value of the 2019 Warrants.

Retail

                                     Three months ended September 30,                          Percent
                                         2022                   2021             Change        Change
Revenues                          $         3,080,778     $        855,841    $   2,224,937        260 %
Costs and expenses                        (2,413,190)            (891,126)      (1,522,064)        171 %
                                  $           667,588     $       (35,285)    $     702,873    (1,992) %


                                    Nine months ended September 30,                         Percent
                                        2022                 2021             Change        Change
Revenues                         $        9,536,657     $       855,841    $   8,680,816      1,014 %
Costs and expenses                      (7,169,103)           (891,126)    

(6,277,977) 704 % Segment operating income $ 2,367,554 $ (35,285) $ 2,402,839 (6,810) %




With the addition of the TREES Englewood dispensary on September 2, 2021, Trees
Portland and Trees Waterfront on December 30, 2021, and Trees MLK on January 5,
2022, we have established our retail footprint in the Colorado and Oregon
markets and have become a vertically integrated company. The Retail Segment will
provide consistent positive cash flows which will significantly contribute to
our working capital position.

                                       26

  Table of Contents

Cultivation

                         Three months ended September 30,                       Percent
                            2022                  2021             Change       Change
Revenues              $         448,623     $         835,719    $ (387,096)       (46) %
Costs and expenses            (849,269)             (865,490)         16,221        (2) %
                      $       (400,646)     $        (29,771)    $ (370,875)      1,246 %


                        Nine months ended September 30,                      Percent
                            2022                 2021           Change       Change
Revenues              $       1,316,241     $    2,183,660    $ (867,419)       (40) %
Costs and expenses          (1,971,550)        (2,340,913)        369,363       (16) %
                      $       (655,309)     $    (157,253)    $ (498,056)        317 %


The decrease in revenues for the three and nine months ended September 30, 2022,
over prior year is due to the decrease in overall market price of flower. The
decrease in gross margin is due to overall increase in expenses due to
inflation.

Liquidity

Sources of liquidity

Our sources of liquidity include cash generated from operations, the cash
exercise of common stock options and warrants, debt, and the issuance of common
stock or other equity-based instruments. We anticipate our significant uses of
resources will include funding operations and developing infrastructure.

In September 2022, we received $10,587,250 in cash, of which $4,037,500 is held
in restricted cash for future acquisitions. We received the cash in a private
placement with certain accredited investors pursuant to the 12% Notes to be used
for acquisition of dispensaries and operating capital.

In September 2021, we received $1,180,000 in cash in a private placement with
certain accredited investors pursuant to the Series A Convertible Preferred
Stock to be used for the acquisition of dispensaries and for operating capital.
(See Note 10 of the accompanying unaudited condensed consolidated financial
statements).

In April 2021, we received $2,300,000 in cash in a private placement with certain accredited investors pursuant to the 10% Notes to be used for the acquisition of dispensaries (See Note 7 of the accompanying unaudited condensed consolidated financial statements).

In February 2021, we received $1,660,000 in cash in a private placement with certain accredited investors pursuant to the 10% Notes (See Note 7 of the accompanying unaudited condensed consolidated financial statements).

Sources and uses of cash

We had cash of $1,964,660 and $2,054,050 as of September 30, 2022, and December 31, 2021, respectively. Our cash flows from operating, investing and financing activities were as follows:



                                                Nine months ended September 

30,


                                                  2022                  

2021


Net cash used in operating activities        $     (894,643)     $      (2,489,130)
Net cash used in investing activities        $     (202,485)     $        (936,719)
Net cash provided by financing activities    $     5,045,238     $        5,134,634

Net cash used in operating activities decreased in 2022 due to the acquisition of TREES Englewood, Trees Portland, Trees Waterfront and Trees MLK which provides positive operating cash flows and adjustments relating to non-cash activities.



Net cash used in investing activities for the nine months ended September 30,
2022, increased from September 30, 2021, due to the purchase of, Trees MLK, Inc
and the purchase of property and equipment, offset by the receipt of notes

receivable.

                                       27

  Table of Contents

Net cash provided by financing activities for the nine months ended September
30, 2022, related to the cash proceeds of the new debt of $10,587,250, offset by
payment on notes payable of $3,987,250.

Capital Resources

We had no material commitments for capital expenditures as of September 30, 2022. Part of our growth strategy, however, is to acquire operating businesses. We expect to fund such activity through cash on hand, the issuance of debt, common stock, warrants for our common stock or a combination thereof.

Non-GAAP Financial Measures


Adjusted EBITDA is a non-GAAP financial measure. We define Adjusted EBITDA
as net income (loss) attributable to common stockholders calculated in
accordance with GAAP, adjusted for the impact of stock-based compensation
expense, acquisition or disposal-related transaction costs , non-recurring
professional fees in relation to litigation and other non-recurring expenses,
depreciation and amortization, amortization of debt discounts and equity
issuance costs, loss on extinguishment of debt, interest expense, income taxes
and certain other non-cash items. Below we have provided a reconciliation of
Adjusted EBITDA per share to the most directly comparable GAAP measure, which is
net income (loss) per share.

We believe that the disclosure of Adjusted EBITDA provides investors with a
better comparison of our period-to-period operating results. We exclude the
effects of certain items when we evaluate key measures of our performance
internally and in assessing the impact of known trends and uncertainties on our
business. We also believe that excluding the effects of these items provides a
more comparable view of the underlying dynamics of our operations. We believe
such information provides additional meaningful methods of evaluating certain
aspects of our operating performance from period to period on a basis that may
not be otherwise apparent on a GAAP basis. This supplemental financial
information should be considered in addition to, not in lieu of, our condensed
consolidated financial statements.

The following table reconciles Adjusted EBITDA to the most directly comparable GAAP measure, which is net loss.



                                            Three months ended September 

30, Nine months ended September 30,


                                               2022                  2021                 2022                 2021
Net loss from continuing operations      $     (2,704,679)     $     (1,327,595)    $     (3,753,966)     $  (5,062,916)
Adjustment for loss from discontinued
operations                                             195                40,605              (5,478)            377,134
Net loss                                       (2,704,484)          

(1,286,990) (3,759,444) (4,685,782) Adjustments: Stock-based compensation

                            38,460               131,836              156,961            194,120
Depreciation and amortization                       98,915               115,355              190,770            305,824
Amortization of debt discount and
equity issuance costs                            1,285,392               216,516            1,716,334            470,306
Loss on extinguishment of debt                     310,622               233,374              310,622            233,374
Interest expense                                   213,833               150,503              564,229            444,186
Gain on sale of assets                                   -             (132,979)             (13,000)          (131,512)
(Gain) loss on derivative liability               (16,365)              (52,452)             (14,959)          1,043,531
Severance                                                -                     -                4,731                  -
Acquisition related expenses                       162,634                35,360              193,956             98,243
Provision for income taxes                         254,000                     -              254,000                  -
Total adjustments                                2,347,491               697,513            3,363,644          2,658,072
Adjusted EBITDA                          $       (356,993)     $       (589,477)    $       (395,800)     $  (2,027,710)

Off-balance Sheet Arrangements

We currently have no off-balance sheet arrangements.



                                       28

  Table of Contents

Critical Accounting Policies

Our unaudited condensed consolidated financial statements and accompanying notes
have been prepared in accordance with U.S. GAAP. The preparation of these
financial statements requires management to make estimates, judgments and
assumptions that affect reported amounts of assets, liabilities, revenues, and
expenses. We continually evaluate the accounting policies and estimates used to
prepare the condensed financial statements. The estimates are based on
historical experience and assumptions believed to be reasonable under current
facts and circumstances. Actual amounts and results could differ from these
estimates made by management. Certain accounting policies that require
significant management estimates and are deemed critical to our results of
operations or financial position are discussed in our Annual Report on Form 10-K
for the year ended December 31, 2021, and Note 1 to the Unaudited Condensed
Consolidated Financial Statements in this Form 10-Q.

© Edgar Online, source Glimpses